Clinical Trials Browser

Phase 3 × OTHER × acalabrutinib × Clear all

NCT05197192 2025-08-17

A Phase-3-trial of Acalabrutinib, Obinutuzumab & Venetoclax Compared to Obinutuzumab and Venetoclax in Previously Untreated Patients With High Risk CLL

Phase 3 Recruiting

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT05820841 2023-08-31

ARCHED

Phase 3 Recruiting

Lymphoma, Large B-Cell, Diffuse